Description

Rekvina Laboratories Ltd. equity shares will be moved to 'X' group effective January 20, 2026.

Summary

BSE has announced that the equity shares of Rekvina Laboratories Ltd. (Scrip Code: 526075) will be transferred to the ‘X’ group effective January 20, 2026. This reclassification is communicated to all trading members.

Key Points

  • Company: Rekvina Laboratories Ltd.
  • Scrip Code: 526075
  • Change: Inclusion under ‘X’ group
  • Effective Date: January 20, 2026
  • Notice Number: 20260113-11
  • Contact: Mrs. Kinjal More (+91-7304278788) for clarifications

Regulatory Changes

The equity shares will be moved from their current group classification to the ‘X’ group, which typically indicates securities under additional surveillance or those that don’t meet regular trading group criteria.

Compliance Requirements

Trading members should:

  • Be aware of the group change effective January 20, 2026
  • Adjust trading strategies and risk assessments accordingly
  • Contact Mrs. Kinjal More for any clarifications needed

Important Dates

  • Notice Date: January 13, 2026
  • Effective Date: January 20, 2026

Impact Assessment

The movement to ‘X’ group may result in:

  • Increased trading restrictions or surveillance measures
  • Potential impact on liquidity and trading volumes
  • Enhanced monitoring requirements for the security
  • Investors should exercise additional caution when trading these shares

Impact Justification

Movement to X group indicates increased surveillance or risk classification for the stock, affecting trading conditions and investor awareness